3-aminopyrazole inhibitors of cyclin dependent kinases

Details for Australian Patent Application No. 2001229727 (hide)

Owner Bristol-Myers Squibb Company

Inventors Salvati, Mark E.; Kimball, Spencer David

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001229727

PCT Pub. Number WO01/57034

Priority 60/180,609 07.02.00 US

Filing date 23 January 2001

Wipo publication date 14 August 2001

Acceptance publication date 14 October 2004

International Classifications

C07D 413/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61P 035/00 Antineoplastic agents

A61K 031/42 - Oxazoles

Event Publications

14 October 2004 Application Accepted

  Published as AU-B-2001229727

10 February 2005 Standard Patent Sealed

13 September 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001229728

2001229726